Insights

Nathaniel Lipkus Nathaniel Lipkus

Type (0)

Results

All Insights

Osler Update June 6, 2016

$125-million pharmaceutical damages award undone by hearsay rule

The Court questioned Teva’s ability to supply the market due to its reliance on inadmissible hearsay evidence. The judgment is expected to have...

Read more